Formulex Pharma Innovations

Company Overview

Snapshot

Founded in July 2001, Formulex Pharma Innovations operates with 1–10 employees. The company has raised $55 million across two funding rounds. In June 2010, Dr. Amir Zalcenstein was appointed CEO of SoluBest, the predecessor to Formulex Pharma Innovations, signaling a leadership transition for the nanotechnology-based drug delivery firm.

Business overview

Formulex Pharma Innovations specializes in nanotechnology-based drug delivery and formulation, continuing the work of its predecessor, SoluBest Ltd. The company develops innovative formulation solutions for biopharmaceuticals, nutraceuticals, and agrochemicals, serving clients in Israel and globally. Its core technology, Solumer, utilizes sub-micron-particle engineering and proprietary spray drying processes to enhance the solubility, bioavailability, and physical stability of drug substances. Formulex Pharma Innovations operates within the Health Tech & Life Sciences sector, with a focus on Pharma & Medical Biotechnology, Medical Cannabis, and Drug Delivery.

Strategic signal

In June 2010, Dr. Amir Zalcenstein was appointed CEO of SoluBest, the entity whose activities Formulex Pharma Innovations continues. This leadership change signaled a strategic move to potentially drive forward the company's nanotechnology-based drug delivery and formulation efforts, indicating a focus on executive talent to steer its development in the pharmaceutical and biotechnology sectors.

Company Intelligence Q&A

What is Formulex Pharma Innovations' primary focus?

Formulex Pharma Innovations focuses on nanotechnology-based drug delivery and formulation, developing innovative solutions for biopharmaceuticals, nutraceuticals, and agrochemicals.

When was Formulex Pharma Innovations founded?

Formulex Pharma Innovations was founded in July 2001.

What is the total capital raised by Formulex Pharma Innovations?

Formulex Pharma Innovations has raised $55 million across two funding rounds.

What is the Solumer technology?

Solumer is a patented technology developed by Formulex Pharma Innovations (originally SoluBest) that uses sub-micron-particle engineering and proprietary spray drying to maximize the solubility, bioavailability, and physical stability of drug substances.

Has Formulex Pharma Innovations developed products for medical cannabis?

Yes, Formulex Pharma Innovations has developed more than 10 medical cannabis products using its patented Solumer and generic technologies, with five products currently in clinical and commercial stages.